Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02483793
Study type Interventional
Source Phoenix Children's Hospital
Contact Michael Nguyen, MD
Phone (602) 933-5200
Email mtn1023@hotmail.com
Status Not yet recruiting
Phase N/A
Start date July 2015
Completion date December 2016

See also
  Status Clinical Trial Phase
Completed NCT01959074 - The Effect of Naftopidil for the Double-J Stent Discomfort Phase 3
Completed NCT02140970 - Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal N/A
Completed NCT01530243 - The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms Phase 2/Phase 3
Active, not recruiting NCT02007980 - Indwelling Stent Discoloration Project